MariMed (OTCMKTS:MRMD) Posts Quarterly Earnings Results

MariMed (OTCMKTS:MRMD) issued its earnings results on Wednesday. The company reported ($0.01) EPS for the quarter, meeting the consensus estimate of ($0.01), Zacks reports. MariMed had a negative net margin of 7.82% and a negative return on equity of 4.82%. The company had revenue of $39.48 million during the quarter, compared to analysts’ expectations of $38.75 million.

MariMed Price Performance

MRMD opened at $0.08 on Friday. The company has a quick ratio of 0.38, a current ratio of 1.00 and a debt-to-equity ratio of 1.44. MariMed has a 12 month low of $0.06 and a 12 month high of $0.23. The company has a fifty day simple moving average of $0.08 and a 200 day simple moving average of $0.09. The stock has a market cap of $32.39 million, a P/E ratio of -2.71 and a beta of 1.33.

About MariMed

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.